Ralph Laufer
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, Neuropeptides and Animal Physiology, HIV Research and Treatment, Chemical Synthesis and Analysis
Most-Cited Works
- → Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection(2008)627 cited
- → Response of melanocortin–4 receptor–deficient mice to anorectic and orexigenic peptides(1999)546 cited
- → Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation(1999)325 cited
- → Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance(1997)215 cited
- → Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor(2016)133 cited
- → Activity-dependent regulation of gene expression in muscle and neuronal cells(1989)133 cited
- → Behavioural effects of receptor-specific substance P agonists(1987)131 cited
- → Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer(2000)126 cited
- → 4,5-Dihydroxypyrimidine Carboxamides and N-Alkyl-5-hydroxypyrimidinone Carboxamides Are Potent, Selective HIV Integrase Inhibitors with Good Pharmacokinetic Profiles in Preclinical Species(2006)99 cited
- → HCV NS5b RNA-Dependent RNA Polymerase Inhibitors: From α,γ-Diketoacids to 4,5-Dihydroxypyrimidine- or 3-Methyl-5- hydroxypyrimidinonecarboxylic Acids. Design and Synthesis(2004)91 cited